von Willebrand's disease. Pathogenesis and clinical aspects
- 31 August 1993
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 15 (1) , 1-11
- https://doi.org/10.1016/1040-8428(93)90016-w
Abstract
No abstract availableThis publication has 93 references indexed in Scilit:
- Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type IIIAnnals of Hematology, 1992
- Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type IAnnals of Hematology, 1990
- Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.Journal of Clinical Investigation, 1988
- Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous TransfusionsNew England Journal of Medicine, 1987
- The size of human factor VIII heterodimers and the effects produced by thrombinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Platelet Aggregation Induced by I-Desamino-8-D-Arginine Vasopressin (dDAVP) in Type IIb von Willebrand's DiseaseNew England Journal of Medicine, 1983
- DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand diseaseThe Journal of Pediatrics, 1983
- Pseudo-von Willebrand's DiseaseNew England Journal of Medicine, 1982
- Heightened Interaction between Platelets and Factor VIII/von Willebrand Factor in a New Subtype of von Willebrand's DiseaseNew England Journal of Medicine, 1980
- v. Willebrand's Disease and its Correction with Human Plasma Fraction 1‐0Acta Medica Scandinavica, 1957